NCT05015634

Telemedicine in High-Risk Cardiovascular Patients Post-ACS

Remote Acute Assessment of Patients With High Cardiovascular Risk Post-Acute Coronary Syndrome

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 337 (actual)
• Sponsor: Imperial College London · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a non-CTIMP randomised controlled trial looking at the utilisation of telemedicine devices to provide remote, clinically necessary, diagnostic information, without the need for hospital attendance that patients will take home with them following admission to hospital with a heart attack.

Detailed description

Following hospital admission with a heart attack, telemedicine equipment can provide patients with remote, clinically necessary diagnostic information without the need for hospital attendance, which they can take home when they discharge from the hospital. In this project, patients known to be at high risk of ACS are equipped and empowered to seek urgent medical attention without visiting the hospital, if they experience symptoms, and to determine whether or not to seek emergency treatment, with an immediate remote specialist consultation, as assessed by validated technology. Those enrolled in the intervention group will be offered telemedicine packages upon discharge from the hospital. Those enrolled in the active arm will have their telemedicine package provided to the trial team when they conduct an ECG and seek medical attention. In contrast, in the control group, routine clinical care will be provided, as well as follow up by phone over 9 months.

Conditions

• Cardiovascular Diseases
• Acute Coronary Syndrome

Interventions

Type	Name	Description
OTHER	Active Arm	Patient develops possible cardiac symptoms, takes an ECG, BP and oxygen saturation as per their training. Patient will receive a phone call by the trial cardiologist who will have access to a high-quality ECG trace, as well as blood pressure and oxygen saturations, and coupled with the clinical history, can decide on the most appropriate course of further management. With remote follow up over the phone at 3, 6 and 9 months.
OTHER	Control Arm	Standard routine clinical care will be carried out, with remote follow up over the phone at 3, 6 and 9 months.

Timeline

• Start date: 2022-01-06
• Primary completion: 2025-02-28
• Completion: 2025-05-31
• First posted: 2021-08-20
• Last updated: 2026-03-17
• Results posted: 2026-02-23

Locations

1 site across 1 country: United Kingdom